Another new crown vaccine in the UK has begun human trials

, June 25 (Zhao Xingyi Zhangping) Britain's Imperial College research team announced to the outside world on the 24th, its research and development of a new crown vaccine on the same day began to vaccinate volunteers. This is the second new corona vaccine to enter the human trial phase after the Oxford University developed the vaccine in April.
, a professor at Imperial College London, said the vaccine completed the previous phase of animal trials. Test results show that the vaccine is safe and can trigger an effective immune response. About 300 volunteers will be vaccinated in the coming weeks. The next phase of human trials is scheduled for October, and the number of inoculations will be expanded to 6,000.
based on a new method that uses a synthetic chain of genetic code called RNA to mimic the new coronavirus, according to Satok. Once the vaccine is injected into the body's muscles, RNA replicates itself, instructing the body's own cells to replicate the virus's external prick protein, prompting the immune system to recognize and fight the new coronavirus, thus preventing the body from contracting the virus.
, lead researcher on the study and an infectious disease expert at Imperial College London, said she was "cautiously optimistic" about the results.
Shartok said that "we have been able to produce vaccines from scratch and conduct human trials in just a few months" and that "if our approach is effective, vaccines can provide effective protection to people and could revolutionized the way we respond to new coronavirus outbreaks in the future".
research at Imperial College uk received a grant of 41 million pounds from the British government and a social donation of 5 million pounds. The team hopes the vaccine will be available in the UK and overseas from early 2021. (Complete)